Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.345 USD | +2.92% | +5.19% | +121.52% |
17/04 | RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk | MT |
10/04 | Nuvation Bio Closes Acquisition of AnHeart Therapeutics | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+121.52% | 854M | |
+26.92% | 44.96B | |
-0.63% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.38% | 26.08B | |
-21.43% | 19.03B | |
+6.07% | 12.75B | |
+27.79% | 12.06B | |
-3.27% | 11.75B |
- Stock Market
- Equities
- NUVB Stock
- News Nuvation Bio Inc.
- HC Wainwright Adjusts Nuvation Bio's Price Target to $8 From $5, Maintains Buy Rating